Abstract
The tumour suppressor p53 is a transcriptional regulator whose ability to inhibit cell growth is dependent upon its transactivation function1,2,3. Here we demonstrate that the transcription factor CBP, which is also implicated in cell proliferation and differentiation4,5,6,7,8,9,10,11,12,13,14, acts as a p53 coactivator and potentiates its transcriptional activity. The amino-terminal activation domain of p53 interacts with the carboxy-terminal portion of the CBP protein both in vitro and in vivo. In transfected SaoS-2 cells, CBP potentiates activation of the mdm-2 gene by p53 and, reciprocally, p53 potentiates activation of a Gal4-responsive target gene by a Gal4(1–147)–CBP(1678–2441) fusion protein. A double point mutation that destroys the transactivation function of p53 also abolishes its binding to CBP and its synergistic function with CBP. The ability of p53 to interact physically and functionally with a co-activator (CBP) that has histone acetyltransferase activity15,16 and with components (TAFs)17,18 of the general transcription machinery indicates that it may have different functions in a multistep activation pathway.
Similar content being viewed by others
References
Ko, L. J. & Prives, C. p53: puzzle and paradigm. Genes Dev. 10, 1054–1072 (1996).
El-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).
Wu, X., Bayle, J. H., Olson, D. & Levine, A. J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126–1132 (1993).
Chrivia, J. C. et al. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855–859 (1993).
Yang, X. J., Ogryzko, V. V., Nishikawa, J., Howard, B. H. & Nakatani, Y. Ap300/CBP-associated factor that competes with the adenoviral oncoprotein E1a. Nature 382, 319–324 (1996).
Kwok, R. P. et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223–226 (1994).
Arias, J. et al. Activation of cAMP and mitogen responsive gene relies on a common nuclear factor. Nature 370, 226–229 (1994).
Arany, Z., Newsome, D., Oldread, E., Livingston, D. M. & Eckner, R. Afamily of transcriptional adaptor proteins targeted by the E1a oncoprotein. Nature 374, 81–84 (1995).
Lundblad, J. R., Kwok, R. P., Laurance, M. E., Harter, M. L. & Goodman, R. H. Adenoviral E1a-associated protein p300 as a functional homologue of the transcriptional coactivator CBP. Nature 374, 85–88 (1995).
Banister, A. J. & Kouzarides, T. CBP-induced stimulation of c-Fos activity is abrogated by E1a. EMBO J. 14, 4758–4762 (1995).
Dai, P. et al. CBP as a transcriptional coactivator of c-Myb. Genes Dev. 10, 528–540 (1996).
Kamei, Y. et al. ACBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403–414 (1996).
Chakravati, D. et al. Roles of CBP/p300 in nuclear receptor signalling. Nature 383, 99–103 (1996).
Lee, J. S., See, R. H., Deng, T. & Shi, Y. Adenovirus E1a downregulates c-Jun and JunB-mediated transcription by targeting their coactivator p300. Mol. Cell. Biol. 16, 4312–4326 (1996).
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H. & Nakatani, Y. The transcriptional coactivator p300 and CBP are histone acetyltransferase. Cell 87, 953–959 (1996).
Bannister, A. J. & Kouzarides, T. The CBP coactivator is a histone acetyltransferase. Nature 384, 641–643 (1996).
Thut, C., Chen, J. L., Klemm, R. & Tjian, R. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science 267, 100–104 (1995).
Lu, H. & Levine, A. J. Human TAF31 protein is a transcriptional coactivator of the p53 protein. Proc. Natl Acad. Sci. USA 92, 5154–5158 (1995).
Xiao, H. et al. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14, 7013–7024 (1994).
Seto, E. et al. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl Acad. Sci. USA 89, 12028–12032 (1992).
Lin, J., Chen, J., Elenbaas, X. & Levine, A. J. Several hydrophic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1b 55-kD protein. Genes Dev. 8, 1235–1246 (1994).
Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. & Oren, M. Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev. 9, 2170–2183 (1995).
Steegenga, W. T. et al. Adenovirus E1a proteins inhibit activation of transcription by p53. Mol. Cell. Biol. 16, 2101–2109 (1996).
Wong, H. K. & Ziff, E. B. Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters. J. Virol. 68, 4910–4920 (1994).
Godley, L. A. et al. Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev. 10, 836–850 (1996).
Ferreri, K., Gill, G. & Montminy, M. The cAMP-regulated transcription factor CREB interacts with a component of the TFIID complex. Proc. Natl Acad. Sci. USA 91, 1210–1213 (1994).
Onate, S. A., Tsai, S. Y., Tsai, M-J. & O'Malley, B. W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354–1357 (1995).
Voegel, J. J., Heine, M. J. S., Zechel, C., Chambon, P. & Gronemeyer, H. TIF2, a 160 kd transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15, 3667–3675 (1996).
Fondell, J. D., Ge, H. & Roeder, R. G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl Acad. Sci. USA 93, 8329–8333 (1996).
Gu, W., Bhatia, K., Magrath, I. T., Dang, C. V. & Dalla-Favera, R. Binding and suppression of the Myc transcriptional activation domain by p107. Science 264, 251–254 (1994).
Acknowledgements
We thank R. H. Goodman, A. Levine, M. Oren, A. G. Jochemsen, N. C. Jones, A.J.Banister and T. Kouzarides for plasmids; H. Xiao, Y. Tao, L. Wang, S. Stevens and J. D. Fondell for discussions and for critical comments on the manuscript and Y. Nakatani for sharing unpublished observations. This work was supported by a postdoctoral fellowship from Life Science Foundation for Advanced Cancer Studies to W.G., and by grants from the NIH to R.G.R.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gu, W., Shi, XL. & Roeder, R. Synergistic activation of transcription by CBP and p53. Nature 387, 819–823 (1997). https://doi.org/10.1038/42972
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/42972
- Springer Nature Limited
This article is cited by
-
Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness
Cancer Cell International (2022)
-
Deciphering the acetylation code of p53 in transcription regulation and tumor suppression
Oncogene (2022)
-
Transcriptome profiling analysis reveals that ATP6V0E2 is involved in the lysosomal activation by anlotinib
Cell Death & Disease (2020)
-
Loss of SET reveals both the p53-dependent and the p53-independent functions in vivo
Cell Death & Disease (2019)
-
Landscape of the regulatory elements for lysine 2-hydroxyisobutyrylation pathway
Cell Research (2018)